• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性胆汁性肝硬化和原发性硬化性胆管炎的动物模型。

Animal models in primary biliary cirrhosis and primary sclerosing cholangitis.

机构信息

Research Unit for Experimental and Molecular Hepatology, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Graz, Austria.

出版信息

Clin Rev Allergy Immunol. 2015 Jun;48(2-3):207-17. doi: 10.1007/s12016-014-8442-y.

DOI:10.1007/s12016-014-8442-y
PMID:25172178
Abstract

Primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) are immune-mediated cholangiopathies with enigmatic etiology and pathogenesis. They have distinct clinical, laboratory, immunological, and histomorphological characteristics. Well-characterized animal models for PBC and PSC are utterly needed to develop novel pathogenetic concepts and to study innovative treatment strategies. The aim of the current paper is to outline the characteristics of ideal PBC and PSC animal models and to contrast this with a real-life up-to-date overview of currently available mouse models. Although some of this models show several individual characteristics of PBC and PSC, it is obvious that all of them have substantial and important limitations. Nevertheless, some may be beneficial to study certain pathophysiological aspects. Potential cholangiopathy animal models should be systematically investigated in regard to elevated serum alkaline phosphatase, bilirubin, and bile acid levels; immunological abnormalities; and longitudinal studies in regard to their liver phenotype. We herein propose a common systematic workup for potential models based on the fact that there are some intriguing disease combinations in specific genetically modified mice and recommend a stepwise process in regard to model characterization with methodical harvesting and screening of numerous organs for potential concomitant diseases. Due to the complex nature of both cholangiopathies, it seems to be very likely that no single perfect PBC or PSC model will ever be generated. The models outlined herein will certainly help to clarify specific pathogenetic aspects and even more important may turn out to be suitable to test potential drugs for treatment.

摘要

原发性胆汁性胆管炎 (PBC) 和原发性硬化性胆管炎 (PSC) 是具有神秘病因和发病机制的免疫介导性胆管病。它们具有独特的临床、实验室、免疫学和组织形态学特征。迫切需要为 PBC 和 PSC 开发特征明确的动物模型,以提出新的发病机制概念并研究创新的治疗策略。本文旨在概述理想的 PBC 和 PSC 动物模型的特征,并将其与当前可用的小鼠模型的最新实际情况进行对比。尽管其中一些模型显示出 PBC 和 PSC 的一些个别特征,但显然它们都存在重大且重要的局限性。尽管如此,其中一些模型可能有助于研究某些病理生理方面。应根据血清碱性磷酸酶、胆红素和胆汁酸水平升高、免疫异常以及针对其肝表型的纵向研究,系统性地研究潜在的胆管病动物模型。我们在此提出了一种基于特定基因修饰小鼠中存在一些有趣疾病组合的潜在模型的常见系统评估,并建议针对模型特征进行逐步处理,对多个器官进行有针对性的采集和筛选,以发现潜在的伴随疾病。由于这两种胆管病的复杂性,似乎不太可能会生成单一的完美 PBC 或 PSC 模型。本文中概述的模型肯定有助于阐明特定的发病机制方面,甚至更重要的是,可能适合测试用于治疗的潜在药物。

相似文献

1
Animal models in primary biliary cirrhosis and primary sclerosing cholangitis.原发性胆汁性肝硬化和原发性硬化性胆管炎的动物模型。
Clin Rev Allergy Immunol. 2015 Jun;48(2-3):207-17. doi: 10.1007/s12016-014-8442-y.
2
New insights into autoimmune cholangitis through animal models.通过动物模型深入了解自身免疫性胆管炎。
Dig Dis. 2010;28(1):99-104. doi: 10.1159/000282072. Epub 2010 May 7.
3
Characterization of animal models for primary sclerosing cholangitis (PSC).原发性硬化性胆管炎(PSC)动物模型的特征描述。
J Hepatol. 2014 Jun;60(6):1290-303. doi: 10.1016/j.jhep.2014.02.006. Epub 2014 Feb 19.
4
Phenotyping and auto-antibody production by liver-infiltrating B cells in primary sclerosing cholangitis and primary biliary cholangitis.原发性硬化性胆管炎和原发性胆汁性胆管炎中肝内浸润 B 细胞的表型和自身抗体产生。
J Autoimmun. 2017 Feb;77:45-54. doi: 10.1016/j.jaut.2016.10.003. Epub 2016 Oct 24.
5
Impact of Microbes on the Pathogenesis of Primary Biliary Cirrhosis (PBC) and Primary Sclerosing Cholangitis (PSC).微生物对原发性胆汁性肝硬化(PBC)和原发性硬化性胆管炎(PSC)发病机制的影响。
Int J Mol Sci. 2016 Nov 9;17(11):1864. doi: 10.3390/ijms17111864.
6
[Novel Insights of Primary Sclerosing Cholangitis and Primary Biliary Cholangitis].[原发性硬化性胆管炎和原发性胆汁性胆管炎的新见解]
Korean J Gastroenterol. 2020 May 25;75(5):246-256. doi: 10.4166/kjg.2020.75.5.246.
7
Will we ever model PSC? - "it's hard to be a PSC model!".我们能建立 PSC 的模型吗?- “成为 PSC 的模型太难了!”。
Clin Res Hepatol Gastroenterol. 2011 Dec;35(12):792-804. doi: 10.1016/j.clinre.2011.04.014. Epub 2011 Jun 23.
8
Primary biliary cirrhosis and primary sclerosing cholangitis.原发性胆汁性肝硬化和原发性硬化性胆管炎。
Clin Liver Dis. 1999 Aug;3(3):529-70. doi: 10.1016/s1089-3261(05)70084-2.
9
Recurrence of primary sclerosing cholangitis, primary biliary cholangitis and auto-immune hepatitis after liver transplantation.肝移植后原发性硬化性胆管炎、原发性胆汁性胆管炎和自身免疫性肝炎的复发
Best Pract Res Clin Gastroenterol. 2017 Apr;31(2):187-198. doi: 10.1016/j.bpg.2017.04.004. Epub 2017 Apr 12.
10
Preclinical insights into cholangiopathies: disease modeling and emerging therapeutic targets.胆管疾病的临床前研究进展:疾病建模与新兴治疗靶点
Expert Opin Ther Targets. 2019 Jun;23(6):461-472. doi: 10.1080/14728222.2019.1608950. Epub 2019 Apr 22.

引用本文的文献

1
infection induces autoimmune hepatitis in mice.感染可诱发小鼠自身免疫性肝炎。
J Transl Autoimmun. 2025 Jan 24;10:100275. doi: 10.1016/j.jtauto.2025.100275. eCollection 2025 Jun.
2
Liver GPBAR1 Associates With Immune Dysfunction in Primary Sclerosing Cholangitis and Its Activation Attenuates Cholestasis in Abcb4-/- Mice.肝脏GPBAR1与原发性硬化性胆管炎中的免疫功能障碍相关,其激活可减轻Abcb4-/-小鼠的胆汁淤积。
Liver Int. 2025 Feb;45(2):e16235. doi: 10.1111/liv.16235.
3
Genetic link between primary biliary cholangitis and connective tissue diseases in European populations: A two-sample Mendelian randomization study.

本文引用的文献

1
Distinct from its canonical effects, deletion of IL-12p40 induces cholangitis and fibrosis in interleukin-2Rα(-/-) mice.与经典作用不同,IL-12p40 缺失可诱导白细胞介素-2Rα(-/-)小鼠发生胆管炎和纤维化。
J Autoimmun. 2014 Jun;51:99-108. doi: 10.1016/j.jaut.2014.02.009. Epub 2014 Mar 17.
2
Loss of liver E-cadherin induces sclerosing cholangitis and promotes carcinogenesis.肝 E-钙黏蛋白缺失导致硬化性胆管炎并促进肿瘤发生。
Proc Natl Acad Sci U S A. 2014 Jan 21;111(3):1090-5. doi: 10.1073/pnas.1322731111. Epub 2014 Jan 6.
3
Imaging of the murine biliopancreatic tract at 7 Tesla: technique and results in a model of primary sclerosing cholangitis.
原发性胆汁性胆管炎与欧洲人群结缔组织病的遗传关联:两样本孟德尔随机化研究。
PLoS One. 2024 Feb 9;19(2):e0298225. doi: 10.1371/journal.pone.0298225. eCollection 2024.
4
Clinical and Immunological Features, Genetic Variants, and Outcomes of Patients with CD40 Deficiency.CD40 缺陷患者的临床和免疫学特征、遗传变异及转归。
J Clin Immunol. 2023 Dec 22;44(1):17. doi: 10.1007/s10875-023-01633-1.
5
Human vascularized bile duct-on-a chip: a multi-cellular micro-physiological system for studying cholestatic liver disease.人源化血管化胆管芯片:用于研究胆汁淤积性肝病的多细胞微生理系统。
Biofabrication. 2023 Oct 20;16(1):015004. doi: 10.1088/1758-5090/ad0261.
6
NOTCH signalling - a core regulator of bile duct disease?NOTCH 信号通路——胆管疾病的核心调控因子?
Dis Model Mech. 2023 Sep 1;16(9). doi: 10.1242/dmm.050231. Epub 2023 Aug 22.
7
Metabolomic Analysis Reveals the Therapeutic Effects of MBT1805, a Novel Pan-Peroxisome Proliferator-Activated Receptor Agonist, on α-Naphthylisothiocyanate-Induced Cholestasis in Mice.代谢组学分析揭示新型泛过氧化物酶体增殖物激活受体激动剂MBT1805对α-萘基异硫氰酸酯诱导的小鼠胆汁淤积的治疗作用。
Front Pharmacol. 2021 Oct 29;12:732478. doi: 10.3389/fphar.2021.732478. eCollection 2021.
8
Mammalian Target of Rapamycin Complex 2 Signaling Is Required for Liver Regeneration in a Cholestatic Liver Injury Murine Model.哺乳动物雷帕霉素靶蛋白复合物 2 信号在胆汁淤积性肝损伤小鼠模型中对肝脏再生是必需的。
Am J Pathol. 2020 Jul;190(7):1414-1426. doi: 10.1016/j.ajpath.2020.03.010. Epub 2020 Apr 7.
9
Animal Models of Autoimmune Liver Diseases: a Comprehensive Review.自身免疫性肝病的动物模型:全面综述。
Clin Rev Allergy Immunol. 2020 Apr;58(2):252-271. doi: 10.1007/s12016-020-08778-6.
10
Preclinical insights into cholangiopathies: disease modeling and emerging therapeutic targets.胆管疾病的临床前研究进展:疾病建模与新兴治疗靶点
Expert Opin Ther Targets. 2019 Jun;23(6):461-472. doi: 10.1080/14728222.2019.1608950. Epub 2019 Apr 22.
7特斯拉小鼠胆胰管成像:技术及在原发性硬化性胆管炎模型中的结果
J Magn Reson Imaging. 2014 Dec;40(6):1355-64. doi: 10.1002/jmri.24475. Epub 2013 Nov 13.
4
Time to say goodbye to the drug or the model? - why do drugs fail to live up to their promise in bile duct ligated mice?是时候告别这种药物或模型了吗?——为什么药物在胆管结扎小鼠中未能兑现其承诺?
J Hepatol. 2014 Jan;60(1):12-5. doi: 10.1016/j.jhep.2013.09.019. Epub 2013 Sep 29.
5
CD8 T cells primed in the gut-associated lymphoid tissue induce immune-mediated cholangitis in mice.肠道相关淋巴组织中致敏的 CD8 T 细胞可诱导小鼠免疫介导性胆管炎。
Hepatology. 2014 Feb;59(2):601-11. doi: 10.1002/hep.26702. Epub 2013 Dec 18.
6
High frequencies of activated B cells and T follicular helper cells are correlated with disease activity in patients with new-onset rheumatoid arthritis.在新诊断的类风湿关节炎患者中,活化的 B 细胞和滤泡辅助 T 细胞的高频与疾病活动度相关。
Clin Exp Immunol. 2013 Nov;174(2):212-20. doi: 10.1111/cei.12162.
7
The immunobiology and pathophysiology of primary biliary cirrhosis.原发性胆汁性肝硬化的免疫生物学和病理生理学。
Annu Rev Pathol. 2013 Jan 24;8:303-30. doi: 10.1146/annurev-pathol-020712-164014.
8
PDX-1/Hes-1 interactions determine cholangiocyte proliferative response to injury in rodents: possible implications for sclerosing cholangitis.PDX-1/Hes-1 相互作用决定了啮齿动物胆管细胞对损伤的增殖反应:对硬化性胆管炎的可能影响。
J Hepatol. 2013 Apr;58(4):750-6. doi: 10.1016/j.jhep.2012.11.033. Epub 2012 Nov 30.
9
Deletion of interleukin (IL)-12p35 induces liver fibrosis in dominant-negative TGFβ receptor type II mice.白细胞介素 (IL)-12p35 的缺失诱导显性负性 TGFβ 受体 II 型小鼠肝纤维化。
Hepatology. 2013 Feb;57(2):806-16. doi: 10.1002/hep.25829.
10
Diagnosis of primary biliary cirrhosis.原发性胆汁性肝硬化的诊断。
Best Pract Res Clin Gastroenterol. 2011 Dec;25(6):701-12. doi: 10.1016/j.bpg.2011.10.005.